New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift

Read more

Could rotavirus vaccine platforms aid in the immunization campaign against SARS-CoV-2?

Rotavirus is a common diarrheal disease that affects young children. Live oral rotavirus vaccines have been used to reduce its

Read more